Ketamine for Suicidal Thoughts
(KEDS-C Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This pilot study aims to evaluate the feasibility and acceptability of administering intramuscular ketamine for the acute reduction of suicidal distress during psychiatric boarding at the Evanston Hospital ED. This study also aims to identify and describe the broader patient population who present to the Evanston Hospital ED in suicidal distress. This study includes several cohorts. A small (n=8) dosing cohort will receive an IM injection of ketamine. Additionally, an ED staff cohort and a research staff cohort can complete optional surveys to provide feedback about study procedures. Lastly, a chart review will be conducted after the completion of the study to determine the volume and patterns of patients who present to Evanston Hospital ED in suicidal distress.
Are You a Good Fit for This Trial?
This trial is for adults who come to the Evanston Hospital Emergency Department with suicidal thoughts or distress. People may not be able to join if they have certain medical conditions, but specific exclusions are not listed here.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Ketamine
Trial Overview
The study is testing a single intramuscular injection of ketamine (0.5 mg/kg) to see if it quickly reduces suicidal distress in patients waiting for psychiatric care in the emergency department.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Group that receives IM ketamine
Find a Clinic Near You
Who Is Running the Clinical Trial?
Endeavor Health
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.